Company profile
Avita Medical Inc.
NASDAQ: RCEL · Healthcare · Medical - Devices
PublicHQ Valencia, CACIK 0001762303Reports USD
#388 of 1,418 Healthcare companies by revenue56th-percentile growth
EA Score
50DFH 45DQ 49GM 59SS 68
v0.1 · 65/100 weight · provisional
↑ workforce scale, 3-yr revenue growth · ↓ balance-sheet leverage, disclosure history
Methodology →Revenue TTM
$72.3M
Rev growth YoY (TTM)
+1.0%
Net income (FY)
-$48.6M
Employees
226
as of 2026-08-14
Market cap
$199.0M
as of 2026-08-14
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$70.9M$70.9M2025
Net income-$48.6M-$48.6M2025
Operating income-$42.5M-$42.5M2025
Total assets$56.4M$56.4M2025
Liabilities$73.0M$73.0M2025
Equity-$16.6M-$16.6M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY21
FY22
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Lease Revenue100%
By geography
UNITED STATES97%
JAPAN3%
AUSTRALIA0%
European Union0%
The read
What is Avita Medical Inc.’s revenue?
Avita Medical Inc. booked $70.9M in FY2025 revenue, growing 11% year over year — about the middle of the pack among Healthcare companies we track, at a -68.5% net margin.
Peers · Healthcare
Omeros Corporation65BAssembly Biosciences, Inc.63CCue Health Inc.——Viridian Therapeutics, Inc.66BCodexis, Inc.61CBlack Diamond Therapeutics, Inc.60CKey facts
CEOCary G. Vance
SectorHealthcare
IndustryMedical - Devices
HeadquartersValencia, CA
ExchangeNASDAQ: RCEL
Employees226
IPO date2012-05-14
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.